RxSight, Inc.·4

Jul 16, 8:15 PM ET

Thunen Shelley B 4

4 · RxSight, Inc. · Filed Jul 16, 2024

Insider Transaction Report

Form 4
Period: 2024-07-15
Thunen Shelley B
See remarks
Transactions
  • Exercise/Conversion

    Common Stock

    2024-07-15$4.34/sh+16,505$71,63230,443 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2024-07-1511,2356,405 total
    Exercise: $4.34From: 2020-10-27Exp: 2026-10-26Common Stock (11,235 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2024-07-155,2701,387 total
    Exercise: $4.34From: 2021-02-24Exp: 2027-03-13Common Stock (5,270 underlying)
Footnotes (1)
  • [F1]Shares issued pursuant to the Issuer's 2015 Equity Incentive Plan, as amended.

Documents

2 files